Healthcare
Live Price
Offline$33.63
+2.00% today
1Y Change
+37.41%
Window
Jun 26, 2025 β Jun 24, 2026
Coverage: 250 bars Β· Jun 26, 2025 β Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Otsuka Holdings Co., Ltd. (OTSKY) is a Healthcare stock with a market cap of $5.92T and listed on OTC. The stock last traded around $33.63 and up 37.4% across the available one-year price window (Jun 26, 2025 β Jun 24, 2026). Baseline metrics include revenue growth of +11.1%, EPS growth of +13.4%, a dividend yield of 1.2%. What stands out right now is revenue +11.1%, EPS +13.4%, free cash flow +47.0% with operating margin 16.0% and ROIC 8.9%. The dividend is present but secondary, with a yield around 1.2%. Valuation is more restrained than many high-expectation growth names at P/E 15.7 and price/sales 2.4. Stock Foundry combines OTSKY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+11.1% vs +7.6% peer median
Operating Margin
Below sector median
+16.0% vs +19.4% peer median
P/E
Below sector median
15.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 29, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +11.1% and EPS at +13.4%, with operating margin around 16.0%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.2%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.9% over the next 5 trading days and finished higher after 2 of those reports.
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 29, 2026 | β | +4.1% | +3.0% | -0.9% |
2026 Feb 13, 2026 | +70.7% | -2.7% | -0.8% | +0.2% |
2025 Oct 31, 2025 | +54.8% | -0.6% | +0.6% | +2.7% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
OTSKY
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
OTSKY Max Drawdown
-14.04%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for OTSKY and SPY.

Company Overview
Otsuka Holdings Co., Ltd.
Other OTC
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTΓ Jelly, a conditioning food product; BODYMAINTΓ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.